// App-Quantinova.ai

: Short-acting ß2-agonists and greenhouse gas emissions in Europe and Canada

Researchers

Presenter

  • Christer Janson

Principal Investigators

  • Ekaterina Maslova

  • Alexander Wilkinson

  • Erika Penz

  • Alberto Papi

  • Nigel Budgen

  • Claus F. Vogelmeier

  • Maciej Kupczyk

  • John Bell

  • Andrew Menzies-Gow

Medical Centers

  • Department of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Lodz, Poland

  • East and North Hertfordshire NHS Trust, Lister, United Kingdom

  • The Royal Marsden Hospital, London, United Kingdom

  • GMA Diabetes, BioPharmaceuticals Med, AstraZeneca, Cambridge, United Kingdom

  • Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-Universität Marburg, Member of the German Center for Lung Research (DZL), Marburg, Germany,

  • Department of Translational Medicine, University of Ferrara, Ferrara, Italy

  • Global Sustainability, AstraZeneca, Macclesfield, United Kingdom

  • 1. Department of Medical Sciences: Respiratory, Allergy and Sleep research, Uppsala University, Uppsala, Sweden

  • Department of Medicine, Division of Respirology, Critical Care and Sleep Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada

Locations

  • Sweden

  • United Kingdom

  • Canada

  • Germany

  • Italy

  • Poland

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved